Literature DB >> 9766264

Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?

C Marcocci1, L Bartalena, A Pinchera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9766264     DOI： 10.1007/BF03347329

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  16 in total

1.  Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.

Authors:  P Vitti; T Rago; L Chiovato; S Pallini; F Santini; E Fiore; R Rocchi; E Martino; A Pinchera
Journal:  Thyroid       Date:  1997-06       Impact factor: 6.568

Review 2.  Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.

Authors:  C Marcocci; L Bartalena; F Bogazzi; G Bruno-Bossio; A Pinchera
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

3.  Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.

Authors:  L J DeGroot; C A Gorman; A Pinchera; L Bartalena; C Marcocci; W M Wiersinga; M F Prummel; L Wartofsky; C ] Marocci C [corrected to Marcocci
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

4.  Surgical treatment of Graves' disease: subtotal or total thyroidectomy?

Authors:  P Miccoli; P Vitti; T Rago; P Iacconi; L Bartalena; F Bogazzi; E Fiore; R Valeriano; L Chiovato; R Rocchi; A Pinchera
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

5.  Surgery still has a role in Graves' hyperthyroidism.

Authors:  N A Patwardhan; M Moront; S Rao; S Rossi; L E Braverman
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

6.  Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but....

Authors:  A Pinchera; L Bartalena; C Marcocci
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

7.  Radioactive iodine therapy for progressive malignant exophthalmos.

Authors:  F K Bauer; B Catz
Journal:  Acta Endocrinol (Copenh)       Date:  1966-01

8.  Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.

Authors:  M F Prummel; W M Wiersinga; M P Mourits; L Koornneef; A Berghout; R van der Gaag
Journal:  Arch Intern Med       Date:  1990-05

9.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; F Bogazzi; L Manetti; M L Tanda; E Dell'Unto; G Bruno-Bossio; M Nardi; M P Bartolomei; A Lepri; G Rossi; E Martino; A Pinchera
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

10.  Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?

Authors:  L Tallstedt; G Lundell; H Blomgren; J Bring
Journal:  Eur J Endocrinol       Date:  1994-05       Impact factor: 6.664
View more
  4 in total

Review 1.  Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy.

Authors:  C Marcocci; M Marinò; R Rocchi; F Menconi; E Morabito; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 2.  Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?

Authors:  L Bartalena; C Marcocci; A Lai; M L Tanda
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

3.  Effect of near-total thyroidectomy on thyroid orbitopathy due to toxic goiter.

Authors:  Yasser A Elsayed; Atif M Abdul-Latif; Mukhtar F Abu-Alhuda; Hosam A-F Halim
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

Review 4.  Relationship between management of hyperthyroidism and course of the ophthalmopathy.

Authors:  L Bartalena; M L Tanda; E Piantanida; A Lai; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.